Details for: NALOXONE HCL INJECTION
Company: SANDOZ CANADA INCORPORATED
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02148706 | NALOXONE HCL INJECTION - 0.4MG/ML USP | NALOXONE HYDROCHLORIDE | 0.4 MG / ML | LIQUID | INTRAMUSCULAR |
| 02148706 | NALOXONE HCL INJECTION - 0.4MG/ML USP | NALOXONE HYDROCHLORIDE | 0.4 MG / ML | LIQUID | INTRAVENOUS |
| 02148706 | NALOXONE HCL INJECTION - 0.4MG/ML USP | NALOXONE HYDROCHLORIDE | 0.4 MG / ML | LIQUID | SUBCUTANEOUS |
| 02148714 | NALOXONE HCL INJECTION - 1MG/ML USP | NALOXONE HYDROCHLORIDE | 1 MG / ML | LIQUID | INTRAMUSCULAR |
| 02148714 | NALOXONE HCL INJECTION - 1MG/ML USP | NALOXONE HYDROCHLORIDE | 1 MG / ML | LIQUID | INTRAVENOUS |
| 02148714 | NALOXONE HCL INJECTION - 1MG/ML USP | NALOXONE HYDROCHLORIDE | 1 MG / ML | LIQUID | SUBCUTANEOUS |
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.